Cargando…
Clinical Remission of Cutaneous Squamous Cell Carcinoma of the Auricle with Cetuximab and Nivolumab
Cutaneous squamous cell carcinomas (SCC) affecting the regions of the head and neck can be challenging to resect surgically and refractory to chemotherapy or radiation therapy. Consequently; the treatment of squamous cell carcinomas of the skin is a focus of current research. One such advancement is...
Autores principales: | Chen, Alessandra, Ali, Nabilah, Boasberg, Peter, Ho, Allen S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5791018/ https://www.ncbi.nlm.nih.gov/pubmed/29320468 http://dx.doi.org/10.3390/jcm7010010 |
Ejemplares similares
-
Case Report: Cetuximab and nivolumab use in advanced cutaneous squamous cell carcinoma resistant to chemotherapy
por: Sernicola, Alvise, et al.
Publicado: (2019) -
Surgical outcomes for cutaneous squamous cell carcinoma of the auricle
por: Manole, Constantin, et al.
Publicado: (2023) -
Nivolumab for Metastatic Cutaneous Squamous Cell Carcinoma
por: Oro-Ayude, Marcos, et al.
Publicado: (2020) -
An extensive squamous cell carcinoma of the auricle: From curative to reconstructive treatment. A case report
por: Halily, Sara, et al.
Publicado: (2022) -
Cetuximab for Immunotherapy-Refractory/Ineligible Cutaneous Squamous Cell Carcinoma
por: Marin-Acevedo, Julian A., et al.
Publicado: (2023)